Skip to main content

Table 1 Grouping of indications for treatment

From: The association between adherence to national antibiotic guidelines and mortality, readmission and length of stay in hospital inpatients: results from a Norwegian multicentre, observational cohort study

  Indication for treatment
Lower respiratory tract infections (LRTI) Community acquired pneumonia (normal and severe), healthcare associated pneumonia (normal and severe), unspecified lower respiratory tract infections, unknown – suspected pneumonia, aspiration pneumonia, atypical pneumonia, lung abscess, empyema.
Acute exacerbations of chronic obstructive pulmonary disease (COPD with LRTI) Patients with COPD, presenting with LRTI (community and healthcare associated)
Sepsis Focus area; lower respiratory tract, urinary tract, unknown focus, soft tissue, abdomen and catheter.
Skin and soft tissue infections (SSTI) Erysipelas, cellulitis, abscess, other skin and soft tissue infections, mastitis, necrotising soft tissue infections, postoperative wound infection.
Gastrointestinal tract infections (GI-infections) Helicobacter pylori-infection, gastroenteritis, peritonitis, cholecystitis/cholangitis, Clostridium difficile (C.Diff).
Urinary tract infections (UTI) UTI – unspecified, pyelonephritis, lower UTI/cystitis, unknown-suspected UTI, catheter associated UTI.
Other infections Suspected both pneumonia and UTI, meningitis, neutropenic fever, osteomyelitis, tonsillitis, arthritis, endocarditis, sinusitis/otitis, and infected intravascular catheters
  1. Indications within each group are given in decreasing order of frequency